BioSyent
2476 Argentia Road,
Mississauga, L5N 6M1, ON,
Canada
Mississauga, L5N 6M1, ON,
Canada
1 905-206-0013
Life Sciences
BioSyent Technographics
BioSyent Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by BioSyent and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 60 BioSyent employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that BioSyent has purchased the following applications: Fitzii Interview Scheduling & Video Screening for Video Interviewing, Interview Scheduling in 2023, Microsoft 365 for Collaboration in 2015, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems BioSyent is running and its propensity to invest more and deepen its relationship with Fitzii , Microsoft , Exclaimer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing BioSyent revenues, which have grown to $22.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for BioSyent intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
BioSyent Tech Stack and Enterprise Applications
BioSyent HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Fitzii | Legacy | Fitzii Interview Scheduling & Video Screening | Video Interviewing, Interview Scheduling | HCM | n/a | 2023 | 2023 |
In 2023, BioSyent implemented Fitzii Interview Scheduling & Video Screening to support HR recruiting in Canada. Public job postings indicate the Fitzii application portal is used for candidate screening and 10 to 15 minute assessments, establishing Fitzii Interview Scheduling & Video Screening as the central candidate assessment entry point for recruiting workflows.
The deployment centers on Video Interviewing,Interview Scheduling capabilities, combining time boxed video assessment workflows with scheduling coordination through the Fitzii portal. Functional configuration appears to include short form video screening assessments, automated interview scheduling, and a candidate portal that centralizes submission and review for talent acquisition teams. Operational scope is HR recruiting in Canada, with the application embedded in public job postings to streamline recruiter intake and standardized first round assessments. Governance and process change focus on orchestration of asynchronous video interviews and scheduled screening events, enabling consistent recruiter review workflows and centralized candidate evaluation.
|
BioSyent Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 BioSyent implemented Microsoft 365 for Collaboration across its corporate environment, provisioning a cloud tenant to support office productivity and internal communications for a company of approximately 60 employees in Canada. Microsoft 365 is described in the deployment context and serves as the central Collaboration platform for email, document management, and team communications.
The deployment emphasized core Collaboration capabilities, including Exchange Online for corporate email, SharePoint Online for intranet and document libraries, OneDrive for personal file sync, Microsoft Teams for messaging and meetings, and the Microsoft 365 suite of desktop and web Office applications. Configuration work focused on document management, version control, shared team sites, and presence and meeting orchestration typical of enterprise Collaboration implementations.
Identity and access governance was implemented using Microsoft identity services for single sign on and group based access controls, with information governance and retention policies aligned to life sciences documentation needs and role based permissions across administrative, commercial, and scientific staff. The company website source code also references Microsoft 365 assets, indicating public facing linkage to the same tenant for contact and hosted content workflows.
|
BioSyent Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, BioSyent implemented Exclaimer Cloud Signatures for Office 365. The deployment is categorized as Digital Signing and is publicly referenced on BioSyent's website, indicating signature assets or rendering are exposed for web display.
The implementation uses centralized signature template management within Exclaimer Cloud Signatures for Office 365, with server side application of signatures into Office 365 mail flow and HTML signature rendering suitable for email and web. Configuration includes dynamic mapping of user attributes from the Office 365 user directory to populate contact and role fields, and templating to enforce consistent branding and disclosure blocks across corporate communications.
Operationally the solution is integrated directly with Office 365 to apply signatures at the mailbox or mail flow layer and is managed through the Exclaimer Cloud administrative console. Governance is implemented via centralized template version control and policy assignment to groups or distribution lists, enabling standardized signature policies across BioSyent's corporate email environment.
|
BioSyent CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2021 | 2021 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
BioSyent PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Transactional Email | PaaS |
|
2021 | 2021 |
|
|
|
|
|
Transactional Email | PaaS |
|
2022 | 2022 |
|
BioSyent IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
BioSyent CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at BioSyent
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by BioSyent Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from BioSyent IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the BioSyent digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD BioSyent Technographics
BioSyent is a Life Sciences organization based in Canada,
with around 60 employees and annual revenues of $22.0 million.
BioSyent operates a diverse technology stack with applications such as
Fitzii Interview Scheduling & Video Screening, Microsoft 365 and Exclaimer Cloud Signatures for Office 365,
covering areas like Video Interviewing, Interview Scheduling, Collaboration and Digital Signing.
BioSyent has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Fitzii, Microsoft and Exclaimer.
BioSyent recently adopted applications including
Fitzii Interview Scheduling & Video Screening in 2023, Twilio Sendgrid in 2022 and Exclaimer Cloud Signatures for Office 365 in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of BioSyent’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates BioSyent’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete BioSyent technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.